Table 3.

Prognostic factors for hospital mortality – univariate analysis.

		Non-survivors	Survivors	p-value
Hematological tumor		27 (77%)	8 (23%)
Solid tumor		38 (55%)	30 (45%)	0.034
Age (median)		61 years	64 years	0.06
Number of organ failure
1		10 (29%)	24 (71%)	<0.00001
>1		55 (80%)	14 (20%)
Cancer status
Progression		22 (67%)	11 (33%)	0.60
Other than progression		43 (61%)	27 (39%)
Cancer phase
Diagnostic		6 (67%)	3 (33%)	0.23
Curative		21 (51%)	20 (49%)
Controllable		38 (72%)	15 (28%)
Immunodepression	No	29 (55%)	24 (45%)	0.07
	Yes	36 (72%)	14 (28%)
ARF origin	Renal	51 (61%)	32 (39%)	0.43
	Mixed	13 (68%)	6 (32%)
Allo/auto graft	No	49 (58%)	36 (42%)	0.01
	Yes	16 (89%)	2 (11%)
ARDS	No	47 (56%)	37 (44%)	0.001
	Yes	18 (95%)	1 (5%)
Mechanical ventilation	No	22 (44%)	28 (56%)	0.0001
	Yes	43 (81%)	10 (19%)
Vasopressor	No	30 (50%)	30 (50%)	0.002
	Yes	35 (81%)	8 (19%)
		Median (range)	Median (range)
SAPS II		57 (28–99)	50 (26–88)	0.022
Bilirubinemia (mg/dl)		1.4 (0.2–19)	0.5 (0.1–5.7)	0.0002
Creatininemia (mg/dl)		3.6 (1.3–18)	4.8 (1.3–20)	0.02
Uremia (mg/dl)		147 (55–492)	154 (49–485)	0.78
Natremia (mEq/l)		139 (122–150)	135 (128–148)	0.01
Kaliemia (mEq/l)		4.7 (3.2–8)	4.5 (2.9–7.8)	0.33
Phosphatemia (mEq/l)		6.2 (2.9–11.3)	6.1 (2.6–14.6)	0.80
Bicarbonate (mEq/l)		19 (6–32)	19 (3–27)	0.64
INR		1.45 (0.97–3.9)	1.33 (0.8–2.9)	0.15
Albuminemia (g/dl)		2.5 (0.7–4)	3.05 (1.7–5.1)	0.0001
Leukocytes (103/mm3)		7.8 (0.02–39)	13 (0.05–50)	0.07

SAPS, Simplified acute physiology score; INR, international normalized ratio; ARF, acute kidney injury; ARDS, acute respiratory distress syndrome.

Bold font highlight the significant variables in univariate analysis.